Hepatocyte growth factor pathway upregulation in the bone marrow microenvironment in multiple myeloma is associated with lytic bone disease.
about
MET/HGF pathway in multiple myeloma: from diagnosis to targeted therapy?Decorin is down-regulated in multiple myeloma and MGUS bone marrow plasma and inhibits HGF-induced myeloma plasma cell viability and migration.Expression of osteoblast and osteoclast regulatory genes in the bone marrow microenvironment in multiple myeloma: only up-regulation of Wnt inhibitors SFRP3 and DKK1 is associated with lytic bone disease.MET dysregulation is a hallmark of aggressive disease in multiple myeloma patients
P2860
Hepatocyte growth factor pathway upregulation in the bone marrow microenvironment in multiple myeloma is associated with lytic bone disease.
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年学术文章
@wuu
2013年学术文章
@zh
2013年学术文章
@zh-cn
2013年学术文章
@zh-hans
2013年学术文章
@zh-my
2013年学术文章
@zh-sg
2013年學術文章
@yue
2013年學術文章
@zh-hant
name
Hepatocyte growth factor pathw ...... iated with lytic bone disease.
@en
Hepatocyte growth factor pathw ...... iated with lytic bone disease.
@nl
type
label
Hepatocyte growth factor pathw ...... iated with lytic bone disease.
@en
Hepatocyte growth factor pathw ...... iated with lytic bone disease.
@nl
prefLabel
Hepatocyte growth factor pathw ...... iated with lytic bone disease.
@en
Hepatocyte growth factor pathw ...... iated with lytic bone disease.
@nl
P2093
P2860
P50
P356
P1476
Hepatocyte growth factor pathw ...... iated with lytic bone disease.
@en
P2093
Ida B Kristensen
Jacob H Christensen
Maria B Lyng
Niels Abildgaard
P2860
P304
P356
10.1111/BJH.12270
P407
P577
2013-02-22T00:00:00Z